201 related articles for article (PubMed ID: 23152132)
1. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells.
An IS; An S; Kwon KJ; Kim YJ; Bae S
Oncol Rep; 2013 Feb; 29(2):523-8. PubMed ID: 23152132
[TBL] [Abstract][Full Text] [Related]
2. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
3. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells.
Shin S; Cha HJ; Lee EM; Lee SJ; Seo SK; Jin HO; Park IC; Jin YW; An S
Int J Oncol; 2009 Jul; 35(1):81-6. PubMed ID: 19513554
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
Cheng CC; Yang SM; Huang CY; Chen JC; Chang WM; Hsu SL
Cancer Chemother Pharmacol; 2005 Jun; 55(6):531-40. PubMed ID: 15739095
[TBL] [Abstract][Full Text] [Related]
5. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles.
Kumar VB; Yuan TC; Liou JW; Yang CJ; Sung PJ; Weng CF
Mutat Res; 2011 Feb; 707(1-2):42-52. PubMed ID: 21185843
[TBL] [Abstract][Full Text] [Related]
6. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
7. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
8. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
Wang Q; Zhong M; Liu W; Li J; Huang J; Zheng L
Exp Lung Res; 2011 Sep; 37(7):427-34. PubMed ID: 21787234
[TBL] [Abstract][Full Text] [Related]
9. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
Lan H; Lin CY; Yuan HY; Xiong B
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
Hu H; Li S; Liu J; Ni B
Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):424-30. PubMed ID: 22491710
[TBL] [Abstract][Full Text] [Related]
11. [Research on the mechanism of ginsenoside Rh2 reversing the resistance of lung adenocarcinoma cells to cisplatin].
Hu S; Yu JY; Xiong LJ; Hu CP; Zhang YX
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):264-8. PubMed ID: 20356543
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract][Full Text] [Related]
13. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.
He X; Li C; Wu X; Yang G
Int J Clin Exp Pathol; 2015; 8(8):9072-80. PubMed ID: 26464649
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
16. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer.
Lev-Ari S; Starr AN; Vexler A; Kalich-Philosoph L; Yoo HS; Kwon KR; Yadgar M; Bondar E; Bar-Shai A; Volovitz I; Schwarz Y
Food Funct; 2021 Sep; 12(17):8068-8077. PubMed ID: 34286798
[TBL] [Abstract][Full Text] [Related]
17. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
Jia WW; Bu X; Philips D; Yan H; Liu G; Chen X; Bush JA; Li G
Can J Physiol Pharmacol; 2004 Jul; 82(7):431-7. PubMed ID: 15389289
[TBL] [Abstract][Full Text] [Related]
18. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer.
Wen X; Zhang HD; Zhao L; Yao YF; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2015; 16(3):1105-9. PubMed ID: 25735339
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
